MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing authorisation application filing ...

Christian Meyer and Gisela Grabow of Maiwald explore proposed changes to new EU provisions aimed at facilitating faster ...

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the ...

SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage cutaneous T-cell lymphoma (CTCL), today announced that it had submitted its ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Healthcare marketing presents a unique challenge While businesses in other sectors can target audiences with fewer restrictions healthcare organizations must comply with stringent regulations designed ...

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.

Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the ...

UK MHRA grants marketing authorization to Amgen’s tarlatamab to treat adult patients with small cell lung cancer: United Kingdom Friday, January 3, 2025, 11:00 Hrs [IST] The UK ...